Back to results
UnknownPhase 2

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

NCT01428414

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Breast cancer institute of Fudan University Cancer Hospital

Shanghai, Shanghai Municipality, China

View on ClinicalTrials.gov
Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer — TrialFind